TY - JOUR
T1 - Optimal control strategy for cancer remission using combinatorial therapy
T2 - A mathematical model-based approach
AU - Das, Parthasakha
AU - Das, Samhita
AU - Das, Pritha
AU - Rihan, Fathalla A A.
AU - Uzuntarla, Muhammet
AU - Ghosh, Dibakar
N1 - Publisher Copyright:
© 2021 Elsevier Ltd
PY - 2021/4
Y1 - 2021/4
N2 - In this article, we develop and analyze a non-linear mathematical model of tumor-immune interactions with combined therapeutic drug and treatment controls. To understand under what circumstances the cancerous cells can be destroyed, an optimal control problem is formulated with treatments as control parameters. By designing a quadratic control based functional, we establish the optimal treatment strategies that maximize the number of immune-effector cells, minimize the number of cancer cells, and detrimental effects caused by the amount of drugs. The necessary and sufficient conditions for optimal control are established. We prove the existence and uniqueness of an optimal control problem. To recognize significant system's parameters, sensitivity analysis are performed for the drug administration and cost functional respectively. We also carry out a cost-effectiveness analysis to determine the most cost-effective therapeutic strategy. The numerical results validate analytical findings and also elucidates that the combinatorial drug therapy can alleviate the cancerous cells under different scenarios.
AB - In this article, we develop and analyze a non-linear mathematical model of tumor-immune interactions with combined therapeutic drug and treatment controls. To understand under what circumstances the cancerous cells can be destroyed, an optimal control problem is formulated with treatments as control parameters. By designing a quadratic control based functional, we establish the optimal treatment strategies that maximize the number of immune-effector cells, minimize the number of cancer cells, and detrimental effects caused by the amount of drugs. The necessary and sufficient conditions for optimal control are established. We prove the existence and uniqueness of an optimal control problem. To recognize significant system's parameters, sensitivity analysis are performed for the drug administration and cost functional respectively. We also carry out a cost-effectiveness analysis to determine the most cost-effective therapeutic strategy. The numerical results validate analytical findings and also elucidates that the combinatorial drug therapy can alleviate the cancerous cells under different scenarios.
KW - Cost-effectiveness analysis
KW - Immuno-chemotherapy
KW - Pontryagin's maximum principle
KW - Sensitivity analysis
KW - Tumor model
UR - http://www.scopus.com/inward/record.url?scp=85101587342&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101587342&partnerID=8YFLogxK
U2 - 10.1016/j.chaos.2021.110789
DO - 10.1016/j.chaos.2021.110789
M3 - Article
AN - SCOPUS:85101587342
SN - 0960-0779
VL - 145
JO - Chaos, Solitons and Fractals
JF - Chaos, Solitons and Fractals
M1 - 110789
ER -